Literature DB >> 23382108

Cytokine profiles in children with primary Epstein-Barr virus infection.

Taizo Wada1, Masahiro Muraoka, Tadafumi Yokoyama, Tomoko Toma, Hirokazu Kanegane, Akihiro Yachie.   

Abstract

Primary Epstein-Barr virus (EBV) infection causes infectious mononucleosis and hemophagocytic lymphohistiocytosis (HLH) in children, where EBV infects B and CD8(+) T cells, respectively. We measured pro-inflammatory and anti-inflammatory cytokines in both diseases. Significantly higher concentrations of various mediators, including interferon-γ, neopterin, interleukin (IL)-6, IL-10, IL-18, and heme oxygenase-1, were observed in EBV-HLH. Because of their similarity to the profile of familial HLH, this profile was likely a consequence of HLH, but not ectopic infection. TNF-α levels were elevated in both diseases. Elevation of those mediators may contribute to the disease pathogenesis of EBV-HLH by activating and inhibiting host immune responses.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23382108     DOI: 10.1002/pbc.24480

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  14 in total

1.  An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma.

Authors:  Tânia Serrão; Alexandra Dias; Pedro Nunes; António Figueiredo
Journal:  BMJ Case Rep       Date:  2015-05-06

2.  Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract?

Authors:  I Friedrichs; T Bingold; O T Keppler; B Pullmann; C Reinheimer; A Berger
Journal:  Med Microbiol Immunol       Date:  2013-07-31       Impact factor: 3.402

3.  Mucosal-associated invariant T cells are activated in an interleukin-18-dependent manner in Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.

Authors:  Yuriko Ishikawa; Masaki Yamada; Naomi Wada; Etsuko Takahashi; Ken-Ichi Imadome
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

Review 4.  Clinical perspectives and therapeutic strategies: pediatric autoinflammatory disease-a multi-faceted approach to fever of unknown origin of childhood.

Authors:  Akihiro Yachie
Journal:  Inflamm Regen       Date:  2022-07-02

5.  BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.

Authors:  Xubing Long; Yuqing Li; Mengtian Yang; Lu Huang; Weijie Gong; Ersheng Kuang
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 6.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

7.  Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.

Authors:  Yuqing Li; Xubing Long; Lu Huang; Mengtian Yang; Yan Yuan; Yan Wang; Henri-Jacques Delecluse; Ersheng Kuang
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

8.  Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.

Authors:  Rupali Das; Peng Guan; Leslee Sprague; Katherine Verbist; Paige Tedrick; Qi Angel An; Cheng Cheng; Makoto Kurachi; Ross Levine; E John Wherry; Scott W Canna; Edward M Behrens; Kim E Nichols
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

Review 9.  Interleukin-18 and IL-18 binding protein.

Authors:  Charles A Dinarello; Daniela Novick; Soohyun Kim; Gilles Kaplanski
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

10.  The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Authors:  J M Krei; H J Møller; J B Larsen
Journal:  Clin Exp Immunol       Date:  2020-11-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.